Preferred Label : Tumor Tissue Origin;

NCIt related terms : Tissue obtained from; TUMTORI;

NCIt definition : A characterization of the tumor tissue site based on whether disease has spread (e.g., primary or metastatic site).;

Alternative definition : CDISC: A characterization of the tumor tissue sample based upon whether it was taken from a tumor that originated after the disease spread.;

NCI Metathesaurus CUI : CL522537;

Details


Main resources

You can consult :


https://campus.neurochirurgie.fr/article1726.html
2023
France
educational course
pineal body
Illness Intrusiveness Rating 7
neoplasms
pinealoma
7-methylbenzanthracene
Clinical Trial Registry Identifier
Loss of Chromosome 7
Smoking Status Not Documented
Tumor Tissue Origin
Neck Pain Score 7
Seven
Clinical Status Ordinal Scale Outcome 7
Pineal Gland
7-methylbenzanthracene
Severity of Symptom Score 7

---
https://campus.neurochirurgie.fr/article1757.html
2023
France
audiovisual aids
neoplasms
ventricle, nos
multimodal imaging
Multimodal Imaging
Ventricular
Tumor Tissue Origin

---
https://campus.neurochirurgie.fr/article1758.html
2023
France
audiovisual aids
Overall Pooled Data
Safety Reporting Documentation
Tumor Tissue Origin
Surgical
Generalized
principle-based ethics
Surgical Procedure
ventricle, nos
general practitioners
Ventricular
policy
neoplasms

---
https://campus.neurochirurgie.fr/article1765.html
2023
France
audiovisual aids
Prevention Study
Preventive Intervention
neoplasms
Tumor Tissue Origin
Ventricular
patient care management
ventricle, nos
Prevention
Complication
Charge
complication, nos

---
https://campus.neurochirurgie.fr/article1768.html
2023
France
audiovisual aids
Cardiac Ventricle
Complication
Postoperative
Ventriculus
complication, nos
Post-Operative
Tumor Tissue Origin
Murine Ventricles, Brain
neoplasms
postoperative complications

---
https://sante.public.lu/fr/actualites/2023/12/rapport-stats-cause-deces-2022.html
2023
Luxembourg
technical report
Blood Circulation
cardiovascular diseases
disease
neoplasms
Tumor Tissue Origin
statistics as topic
luxembourg
death diagnosis
Disease or Disorder
Sample Statistic
Cause of Death
disease of cardiovascular system, nos
Apparatus
Statistics
statistics
cause of death

---
https://campus.neurochirurgie.fr/article1772.html
2023
France
audiovisual aids
Murine Ventricles, Brain
Hydrocephalus, CTCAE
Cardiac Ventricle
Management
Ventriculus
Hydrocephalus
hydrocephalus
Management Occupations
Tumor Tissue Origin
neoplasms

---
https://campus.neurochirurgie.fr/article1755.html
2023
France
audiovisual aids
Youth
adolescent
table, nos
fraud
Neurosurgeons
neurosurgeon
Round
neoplasms
Extramedullary
Tumor Tissue Origin

---
https://pgtmsite.files.wordpress.com/2024/01/mic_msi-h_20210329_final-1.pdf
2021
Canada
drug information
Microsatellite Instability
Treatment
Therapy Object
Treat
Biomaterial Treatment
Treatment Study
During Treatment
Mismatch Repair Protein Deficiency
GDC Treatment Frequency Terminology
Regulatory Report
Clinical Testing
Repair
AML Myeloid Sarcoma Involvement Table
microsatellite instability
albumin/globulin ratio
Device System
Mycobacterium simiae Measurement
Ratio
Intervention Model
evaluation studies as topic
No Treatment for Diabetes
Immune
evaluation report
On Treatment
neoplasms
Treatment Epoch
Tumor Tissue Origin
Clinical Evaluation
Cell Cycle Checkpoint
matched-pair analysis
symptom assessment
Drug Delivery System Category
No Spacing Errors

---
https://pgtmsite.files.wordpress.com/2024/01/re_antipd1-et-msi-h-dmmr_20210629_final.pdf
2021
Canada
drug information
Treat
During Treatment
No Treatment for Diabetes
Immune
Microsatellite Instability
Treatment
Cell Cycle Checkpoint
Biomaterial Treatment
GDC Treatment Frequency Terminology
Use
neoplasms
Mismatch Repair Protein Deficiency
Mycobacterium simiae Measurement
On Treatment
Treatment Epoch
Therapy Object
Treatment Study
Immune Checkpoint Inhibitors
AML Myeloid Sarcoma Involvement Table
Tumor Tissue Origin

---
Nous contacter.
31/10/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.